Search results
‘I Tried Out For A Reality Dating Show But Got Ghosted After My Photos Showed My Psoriasis’
Women's Health via AOL· 4 days agoMichelle Lee had an itchy skin rash from plaque psoriasis for months, but doctors mistook it for an...
FDA Approves Second Ustekinumab Biosimilar
Medscape· 7 days agoThe biosimilar is expected to be marketed in the United States on or after February 21, 2025.
Alvotech, Teva Get FDA Approval for Stelara Biosimilar Psoriasis Treatment
Morningstar· 7 days agoThe treatment is for patients with moderate to severe plaque psoriasis, adults with active psoriatic arthritis and ...
Does the Anti-Inflammatory Diet for Psoriasis Help Manage Symptoms?
Verywell Health via Yahoo News· 1 day agoInflammation is one of the underlying causes of psoriasis, and research shows that an...
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 13 hours agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara®...
Morningstar· 7 days agoFood and Drug Administration (FDA) has approved SELARSDI (ustekinumab-aekn) injection for subcutaneous use, as a biosimilar to Stelara®, for the treatment of moderate to & ...
Stelara biosimilar from Alvotech, Teva approved by FDA
BioPharma Dive via Yahoo Finance· 6 days agoThe FDA cleared Selarsdi for treatment of moderate to severe plaque psoriasis and active psoriatic...
What Can Cause a Rash Around the Eyes?
Verywell Health via Yahoo News· 1 day agoMany conditions can cause a rash around the eyes, from infections to dermatological conditions like dermatitis or psoriasis. Here’s what you need to...
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Ventyx...
Morningstar· 2 days agoDo you, or did you, own shares of Ventyx Biosciences, Inc. (NASDAQ: VTYX)? Did you purchase your shares pursuant and/or traceable to the Company’s October 21, 2021 IPO, or between October 21 ...
FDA approves Alvotech biosimilar of J&J top-selling drug Stelara (NYSE:TEVA)
Seeking Alpha· 7 days agoThe FDA has approved Alvotech’s biosimilar of Johnson & Johnson’s (JNJ) Stelara, with Teva hoping to...